Dis-Chem Pharmacies (JSE:DCP) — Stock Price

ZAC2999.00 ZAC
▼ -0.27% today

Dis-Chem Pharmacies (JSE:DCP) is currently trading at ZAC2999.00 ZAC, down 0.27% today. Over the past 52 weeks, shares have ranged between ZAC2965.00 and ZAC3819.00. This page tracks Dis-Chem Pharmacies's live share price on the JSE exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see Dis-Chem Pharmacies stock valuation.

Dis-Chem Pharmacies (DCP) Stock Price Chart — Daily History & Trading Volume

The chart below tracks Dis-Chem Pharmacies's daily closing share price and trading volume on the JSE exchange over the past year, giving a clear view of recent price momentum and liquidity.

Dis-Chem Pharmacies Income Statement — Revenue, Profit & Earnings by Year

Dis-Chem Pharmacies's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.

Fiscal Year 20252024202320222021
Total Revenue ZAC39.17 Billion ZAC36.28 Billion ZAC32.66 Billion ZAC30.41 Billion ZAC26.28 Billion
Cost of Revenue ZAC30.37 Billion ZAC28.07 Billion ZAC25.08 Billion ZAC23.58 Billion ZAC20.44 Billion
Gross Profit ZAC8.80 Billion ZAC8.22 Billion ZAC7.59 Billion ZAC6.83 Billion ZAC5.84 Billion
Research & Development — — — — —
SG&A ZAC339.41 Million ZAC316.08 Million ZAC268.52 Million ZAC178.17 Million ZAC568.52 Million
Total Operating Expenses ZAC6.70 Billion ZAC6.44 Billion ZAC5.80 Billion ZAC5.20 Billion ZAC4.57 Billion
Operating Income ZAC2.10 Billion ZAC1.78 Billion ZAC1.74 Billion ZAC1.54 Billion ZAC1.27 Billion
EBITDA ZAC3.30 Billion ZAC2.91 Billion ZAC2.75 Billion ZAC2.39 Billion ZAC1.99 Billion
EBIT ZAC2.15 Billion ZAC1.85 Billion ZAC1.74 Billion ZAC1.54 Billion ZAC1.29 Billion
Interest Expense ZAC645.92 Million ZAC586.01 Million ZAC486.14 Million ZAC418.02 Million ZAC417.49 Million
Income Before Tax ZAC1.63 Billion ZAC1.38 Billion ZAC1.42 Billion ZAC1.23 Billion ZAC940.94 Million
Income Tax Expense ZAC414.46 Million ZAC364.09 Million ZAC389.18 Million ZAC337.12 Million ZAC253.29 Million
Net Income ZAC1.18 Billion ZAC984.48 Million ZAC1.00 Billion ZAC853.45 Million ZAC668.69 Million

Dis-Chem Pharmacies Balance Sheet — Assets, Liabilities & Shareholder Equity

The balance sheet below summarizes Dis-Chem Pharmacies's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.

Fiscal Year 20252024202320222021
Total Assets ZAC19.26 Billion ZAC17.50 Billion ZAC15.52 Billion ZAC14.08 Billion ZAC13.19 Billion
Total Current Assets ZAC11.94 Billion ZAC10.92 Billion ZAC9.45 Billion ZAC8.85 Billion ZAC8.42 Billion
Cash & Equivalents — — — — —
Short-term Investments — ZAC68.60 Million — — —
Net Receivables ZAC3.23 Billion ZAC2.64 Billion ZAC2.61 Billion ZAC2.26 Billion ZAC2.04 Billion
Inventory ZAC7.91 Billion ZAC7.16 Billion ZAC6.36 Billion ZAC5.76 Billion ZAC5.69 Billion
Property, Plant & Equipment — — — ZAC3.69 Billion ZAC3.72 Billion
Goodwill ZAC925.99 Million ZAC929.71 Million ZAC873.72 Million ZAC790.63 Million ZAC497.56 Million
Total Liabilities ZAC14.03 Billion ZAC13.03 Billion ZAC11.58 Billion ZAC10.69 Billion ZAC10.24 Billion
Total Current Liabilities ZAC10.18 Billion ZAC9.18 Billion ZAC8.35 Billion ZAC7.51 Billion ZAC6.79 Billion
Long-term Debt ZAC1.68 Billion ZAC1.28 Billion ZAC501.48 Million ZAC479.17 Million ZAC607.21 Million
Net Debt ZAC5.65 Billion ZAC4.81 Billion ZAC4.69 Billion ZAC3.80 Billion ZAC3.94 Billion
Total Stockholder Equity ZAC5.22 Billion ZAC4.47 Billion ZAC3.90 Billion ZAC3.32 Billion ZAC2.91 Billion
Retained Earnings ZAC3.72 Billion ZAC2.97 Billion ZAC2.35 Billion ZAC1.78 Billion ZAC1.37 Billion

Dis-Chem Pharmacies Cash Flow Statement — Operating, Investing & Financing Activities

This cash flow statement breaks down how Dis-Chem Pharmacies generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.

Fiscal Year 20252024202320222021
Operating Cash Flow ZAC904.70 Million ZAC1.89 Billion ZAC853.94 Million ZAC1.38 Billion ZAC1.12 Billion
Capital Expenditures ZAC1.40 Billion ZAC1.03 Billion ZAC1.09 Billion ZAC377.26 Million ZAC401.19 Million
Free Cash Flow ZAC-497.45 Million ZAC863.11 Million ZAC-236.00 Million ZAC1.00 Billion ZAC722.88 Million
Investing Cash Flow ZAC-1.50 Billion ZAC-1.06 Billion ZAC-1.09 Billion ZAC-795.56 Million ZAC-779.75 Million
Financing Cash Flow ZAC-174.64 Million ZAC-631.83 Million ZAC-203.15 Million ZAC-444.61 Million ZAC-498.13 Million
Dividends Paid ZAC-471.99 Million ZAC-424.33 Million ZAC466.01 Million ZAC458.57 Million ZAC39.50 Million
Stock-Based Compensation ZAC28.75 Million ZAC24.23 Million ZAC20.82 Million ZAC18.57 Million ZAC6.41 Million
Depreciation ZAC1.15 Billion ZAC1.06 Billion ZAC1.00 Billion ZAC854.59 Million ZAC704.95 Million
Change in Cash ZAC-765.51 Million ZAC193.40 Million ZAC-441.02 Million ZAC145.04 Million ZAC-164.46 Million

Dis-Chem Pharmacies Earnings History — EPS Actual vs. Analyst Estimates

Track Dis-Chem Pharmacies's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.

Report Date EPS Actual EPS Estimate Surprise
May 29, 2026 — — —
Oct 30, 2025 — — —
May 30, 2025 — — —